"10.1371_journal.pone.0103446","plos one","2014-08-04T00:00:00Z","Kathryn L Hopkins; Fatima Laher; Kennedy Otwombe; Gavin Churchyard; Linda-Gail Bekker; Stephen DeRosa; Maphoshane Nchabeleng; Koleka Mlisana; James Kublin; Glenda Gray","Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Aurum Institute for Health Research, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Medunsa HIV Clinical Research Unit, University of Limpopo, Pretoria, South Africa; Centre for AIDS Programme for Research in South Africa & Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa","Conceived and designed the experiments: KH FL GG. Performed the experiments: GC LGB SD MN KM JK GG. Analyzed the data: KO SD. Contributed reagents/materials/analysis tools: KO SD. Contributed to the writing of the manuscript: KH FL KO SD GG. Performed the literature search: KH. Interpretation of data: KH KO SD. Creating of figures and tables: KH KO. Wrote the paper: KH.","The pharmaceutical company, Merck and Co Inc., sponsored the study products for the HVTN 503/Phambili clinical trial. There are no competing interests to declare, and these study products have not been marketed. This does not alter the authors adherence to PLoS ONE policies on sharing data and materials.","2014","08","Kathryn L Hopkins","KLH",10,FALSE,3,7,2,1,TRUE,FALSE,FALSE,0,NA,FALSE
